Trade Representative, Office of United States Briefing 2026-10-07
Estimated reading time: 5 minutes
1. Notice of Conforming Amendment to Product Exclusion: China’s Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation
Sub: Trade Representative, Office of United States
Content: Effective July 1, 2026, the U.S. International Trade Commission (USITC) implemented certain changes to statistical reporting categories in the Harmonized Tariff Schedule of the United States (HTSUS). As a result of these changes, USTR is making a conforming amendment to an additional product exclusion associated with the Section 301 investigation of China's Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation.
2. Continuation of Actions: China’s Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation
Sub: Trade Representative, Office of United States
Content: In a notice published on May 6, 2026, the Office of the United States Trade Representative (USTR) announced the first step in the second, statutory four-year review process of the two actions taken as a result of the investigation of China's acts, policies, and practices related to technology transfer, intellectual property, and innovation. The notice informed representatives of domestic industries that benefit from the actions, as modified, of the possible termination of the actions and of the opportunity for the representatives to request continuation of the actions. USTR received requests for continuation of both actions from representatives of domestic industries that benefit from the actions. Accordingly, the actions have not terminated and will remain in effect, subject to possible further modifications, including any modifications resulting from the statutory four-year review.
Legal Disclaimer
This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
